Tweet from Bob_Wachter at October 18, 2021 at 04:06PM
Glad the @US_FDA is giving thumbs up to mix-and-match.https://t.co/pW6ce65URV Particularly for J&J recipients, it’s the right call. For Pfizer/Moderna, it offers a bit more flexibility, without much evidence of a meaningful difference. Overall, nice to see the FDA moving faster.
— Bob Wachter (@Bob_Wachter)
Oct 18, 2021